| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000017924 |
| Receipt No. | R000020766 |
| Official scientific title of the study | Effects of anesthetics on depression after modified electroconvulsive treatment |
| Date of disclosure of the study information | 2015/07/06 |
| Last modified on | 2016/12/16 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Effects of anesthetics on depression after modified electroconvulsive treatment | |
| Title of the study (Brief title) | ECT a cross-over test | |
| Region |
|
|
| Condition | |||
| Condition | severe depression | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Effect of ketamine on depression after modified electroconvulsive treatment. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | HAM-D((Hamilton depression score) |
| Key secondary outcomes | Pupil diameter measurement
Hear rate viriability |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | GroupA) Propofol is used in the former half of the period and ketamine is used in the latter half of the period, during ECT procedure. | |
| Interventions/Control_2 | GroupB) Ketamine is used in the former half of the period and propofol is used in the latter half of the period, during ECT procedure. | |
| Interventions/Control_3 | GroupA) Only propofol is used in the former half of the period and combination of ketamine and propofol is used in the latter half of the period, during ECT procedure. | |
| Interventions/Control_4 | GroupB) Only ketamine is used in the former half of the period and combination of ketamine and propofol is used in the latter half of the period, during ECT procedure. | |
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | severe depression | |||
| Key exclusion criteria | 1)Patients with mandatory admission
2)ECT procedure with other procedure 3)Patients with severe coronary artery disease or cerebrovascular disease 4)Severe liver dysfunction 5)Patients with hemodialysis 6)Patients with a permanent pacemaker 7)BMI(Body Mass Index) more than 35 or equal to 35 8)The patient involved in other randomized trail using drugs 9)Patients who were judged as inappropriate by doctors working for this trail |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Shoko Nakano |
| Organization | Osaka Medical College |
| Division name | Department of Anesthesiology |
| Address | 2-7 Daigaku-machi, Takatsuki, Osaka, Japan |
| TEL | 072-683-1221 |
| ane060@osaka-med.ac.jp | |
| Public contact | |
| Name of contact person | Junko Nakahira |
| Organization | Osaka Medical College |
| Division name | Department of Anestheisology |
| Address | 2-7 Daigaku-machi, Takatsuki, Osaka, Japan |
| TEL | 072-683-1221 |
| Homepage URL | |
| ane052@osaka-med.ac.jp | |
| Sponsor | |
| Institute | Osaka Medical College |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Osaka Medical College |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪医科大学付属病院(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | This study was terminated, because results of the same study has been published. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020766 |